| |
Total (980 cases)
|
Success treatment
|
Lost to follow-up
|
Failure
|
Death
|
|---|
| |
N
|
%
|
N
|
%
|
N
|
%
|
N
|
%
|
N
|
%
|
|---|
|
Block II
| | | | | | | | | | |
|
Cavitation
| | | | | | | | | | |
|
Yes
|
753
|
76.8
|
474
|
62.9
|
127
|
16.9
|
62
|
8.2
|
90
|
12.0
|
|
No
|
227
|
23.2
|
147
|
64.8
|
36
|
15.9
|
14
|
6.2
|
30
|
13.2
|
|
Bilateral disease
| | | | | | | | | | |
|
Yes
|
614
|
62.7
|
369
|
60.1
|
101
|
16.4
|
57
|
9.3
|
87
|
14.2
|
|
No
|
366
|
37.3
|
252
|
68.9
|
62
|
16.9
|
19
|
5.2
|
33
|
9.0
|
|
Resistance type
| | | | | | | | | | |
|
Primary
|
231
|
23.6
|
166
|
71.9
|
32
|
13.9
|
15
|
6.5
|
18
|
7.8
|
|
Acquired
|
749
|
76.4
|
455
|
60.7
|
131
|
17.5
|
61
|
8.1
|
102
|
13.6
|
|
Initial resistance pattern
| | | | | | | | | | |
|
MDR/RR
|
965
|
98.5
|
616
|
63.8
|
162
|
16.8
|
74
|
7.7
|
113
|
11.7
|
|
XDR
|
15
|
1.5
|
5
|
33.3
|
1
|
6.7
|
2
|
13.3
|
7
|
46.7
|
|
Initial scheme type
| | | | | | | | | | |
|
Individualized
|
873
|
89.1
|
558
|
63.9
|
142
|
16.3
|
66
|
7.6
|
107
|
12.3
|
|
Standardized
|
107
|
10.9
|
63
|
58.9
|
21
|
19.6
|
10
|
9.3
|
13
|
12.1
|
|
Fluoroquinolone treatment
| | | | | | | | | | |
|
Only used Lfx or Mfx
|
935
|
95.4
|
594
|
63.5
|
158
|
16.9
|
70
|
7.5
|
113
|
12.1
|
|
Only used Ofx
|
12
|
1.2
|
6
|
50.0
|
3
|
25.0
|
2
|
16.7
|
1
|
8.3
|
|
Used more than one fluorquinolone or did not use
|
33
|
3.4
|
21
|
63.6
|
2
|
6.1
|
4
|
12.1
|
6
|
18.2
|
|
Injectable drug treatment
| | | | | | | | | | |
|
Just used Am
|
242
|
24.7
|
151
|
62.4
|
41
|
16.9
|
17
|
7.0
|
33
|
13.6
|
|
Only used S
|
607
|
61.9
|
391
|
64.4
|
103
|
17.0
|
41
|
6.8
|
72
|
11.9
|
|
Only used Cm
|
49
|
5.0
|
30
|
61.2
|
10
|
20.4
|
5
|
10.2
|
4
|
8.2
|
|
Used more than one injectable or did not use
|
82
|
8.4
|
49
|
59.8
|
9
|
11.0
|
13
|
15.9
|
11
|
13.4
|
|
Total
|
980
|
100.0
|
621
|
63.4
|
163
|
16.6
|
76
|
7.8
|
120
|
12.2
|
- MDR multidrug resistant, RR resistant to rifampicin diagnosed by GeneXpert MTB/RIF® (RR), XDR extensively resistant, Lfx levofloxacin, Mfx moxifloxacin, Ofx ofloxacino, Am amikacin, S streptomycin, Cm capreomycin
